Kinetics and utilization of lipid sources during acute exercise and acipimox

American Journal of Physiology - Endocrinology and Metabolism

Volumn 307, Issue 2, 2014, Pages

  Nellemann, Birgitte ^a,b   Søndergaard, Esben ^a   Jensen, Jørgen ^b   Pedersen, Steen Bønløkke ^a   Jessen, Niels ^a   Jørgensen, Jens Otto Lunde ^a   Nielsen, Søren ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b NORWEGIAN SCHOOL OF SPORT SCIENCES   (Norway)

Author keywords

Antilipolysis; Exercise; Lipid oxidation; Very low density lipoprotein

Indexed keywords

ACIPIMOX; DIACYLGLYCEROL ACYLTRANSFERASE 1; DIACYLGLYCEROL ACYLTRANSFERASE 2; FATTY ACID; GLUCOSE TRANSPORTER 4; GLYCOGEN SYNTHASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; LIPOPROTEIN LIPASE; PALMITIC ACID; PLACEBO; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADIPOSE TISSUE; ADULT; ARTICLE; BODY COMPOSITION; BREATH ANALYSIS; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DUAL ENERGY X RAY ABSORPTIOMETRY; EXERCISE; FATTY ACID BLOOD LEVEL; FATTY ACID OXIDATION; GENE EXPRESSION; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; LIPID ANALYSIS; LIPOLYSIS; LUNG GAS EXCHANGE; MALE; MUSCLE BIOPSY; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RANDOMIZED CONTROLLED TRIAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); TRIACYLGLYCEROL BLOOD LEVEL;

ANTILIPOLYSIS; EXERCISE; LIPID OXIDATION; VERY LOW-DENSITY LIPOPROTEIN;

ADULT; EXERCISE; HUMANS; HYPOLIPIDEMIC AGENTS; LIPOLYSIS; LIPOPROTEINS, VLDL; MALE; MIDDLE AGED; MUSCLE, SKELETAL; OVERWEIGHT; PALMITIC ACID; PYRAZINES; TRIGLYCERIDES; YOUNG ADULT;

EID: 84904318699     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00043.2014     Document Type: Article

References (47)

1. Arvidsson S, Kwasniewski M, Riaño-Pachón DM, Mueller-Roeber B. QuantPrime-a flexible tool for reliable high-throughput primer design for quantitative PCR. BMC Bioinformatics 9: 465, 2008.
2. Bianchi A, Evans JL, Iverson AJ, Nordlund AC, Watts TD, Witters LA. Identification of an isozymic form of acetyl-CoA carboxylase. J Biol Chem 265: 1502-1509, 1990.
3. Bondar RJ, Mead DC. Evaluation of glucose-6-phosphate dehydrogenase from Leuconostoc mesenteroides in the hexokinase method for determining glucose in serum. Clin Chem 20: 586-590, 1974.
4. Chen ZP, Stephens TJ, Murthy S, Canny BJ, Hargreaves M, Witters LA, Kemp BE, McConell GK. Effect of exercise intensity on skeletal muscle AMPK signaling in humans. Diabetes 52: 2205-2212, 2003.
5. Clasen BF, Krusenstjerna-Hafstrøm T, Vendelbo MH, Thorsen K, Escande C, Møller N, Pedersen SB, Jørgensen JO, Jessen N. Gene expression in skeletal muscle after an acute intravenous GH bolus in human subjects: identification of a mechanism regulating ANGPTL4. J Lipid Res 54: 1988-1997, 2013.
6. Dyck DJ, Bonen A. Muscle contraction increases palmitate esterification and oxidation and triacylglycerol oxidation. Am J Physiol Endocrinol Metab 275: E888-E896, 1998.
7. Edlund A, Musatti L, Wennmalm A. Acipimox stimulates skin blood flow by a cyclo-oxygenase-dependent mechanism. Eur J Clin Pharmacol 39: 37-41, 1990.
8. Ferrannini E. The theoretical bases of indirect calorimetry: a review. Metabolism 37: 287-301, 1988.
9. Flechtner-Mors M, Jenkinson CP, Alt A, Adler G, Ditschuneit HH. Effects of acipimox on the lipolysis rate in subcutaneous adipose tissue of obese subjects. Diabetes Metab Res Rev 17: 387-390, 2001.
10. Fulcher GR, Walker M, Farrer M, Johnson AS, Alberti KG. Acipimox increases glucose disposal in normal man independent of changes in plasma nonesterified fatty acid concentration and whole-body lipid oxidation rate. Metabolism 42: 308-314, 1993.
11. Gormsen LC, Jensen MD, Nielsen S. Measuring VLDL-triglyceride turnover in humans using ex vivo-prepared VLDL tracer. J Lipid Res 47: 99-106, 2006.
12. Gormsen LC, Jessen N, Gjedsted J, Gjedde S, Nørrelund H, Lund S, Christiansen JS, Nielsen S, Schmitz O, Møller N. Dose-response effects of free fatty acids on glucose and lipid metabolism during somatostatin blockade of growth hormone and insulin in humans. J Clin Endocrinol Metab 92: 1834-1842, 2007.
13. Gormsen LC, Nellemann B, Sørensen LP, Jensen MD, Christiansen JS, Nielsen S. Impact of body composition on very-low-density lipoprotein-triglycerides kinetics. Am J Physiol Endocrinol Metab 296: E165-E173, 2009.
14. Groop LC, Bonadonna RC, Shank M, Petrides AS, DeFronzo RA. Role of free fatty acids and insulin in determining free fatty acid and lipid oxidation in man. J Clin Invest 87: 83-89, 1991.
15. Heiling VJ, Miles JM, Jensen MD. How valid are isotopic measurements of fatty acid oxidation? Am J Physiol Endocrinol Metab 261: E572-E577, 1991.
16. Jensen MD, Heiling V, Miles JM. Measurement of non-steady-state free fatty acid turnover. Am J Physiol Endocrinol Metab 258: E103-E108, 1990.
17. Kanaley JA, Dall R, Møller N, Nielsen SC, Christiansen JS, Jensen MD, Jørgensen JO. Acute exposure to GH during exercise stimulates the turnover of free fatty acids in GH-deficient men. J Appl Physiol (1985) 96: 747-753, 2004.
18. Kanaley JA, Shadid S, Sheehan MT, Guo Z, Jensen MD. Hyperinsulinemia and skeletal muscle fatty acid trafficking. Am J Physiol Endocrinol Metab 305: E540-E548, 2013.
19. Kiens B. Skeletal muscle lipid metabolism in exercise and insulin resistance. Physiol Rev 86: 205-243, 2006.
20. Kok P, Buijs MM, Kok SW, Van Ierssel IH, Frolich M, Roelfsema F, Voshol PJ, Meinders AE, Pijl H. Acipimox enhances spontaneous growth hormone secretion in obese women. Am J Physiol Regul Integr Comp Physiol 286: R693-R698, 2004.
21. Kraus WE, Houmard JA, Duscha BD, Knetzger KJ, Wharton MB, McCartney JS, Bales CW, Henes S, Samsa GP, Otvos JD, Kulkarni KR, Slentz CA. Effects of the amount and intensity of exercise on plasma lipoproteins. N Engl J Med 347: 1483-1492, 2002.
22. Lafferty MJ, Bradford KC, Erie DA, Neher SB. Angiopoietin-like protein 4 inhibition of lipoprotein lipase: Evidence for reversible complex formation. J Biol Chem 288: 28524-28534, 2013.
23. Lewis GF, Uffelman KD, Szeto LW, Weller B, Steiner G. Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans. J Clin Invest 95: 158-166, 1995.
24. Magkos F, Sidossis LS. Measuring very low density lipoprotein-triglyceride kinetics in man in vivo: how different the various methods really are. Curr Opin Clin Nutr Metab Care 7: 547-555, 2004.
25. Mittendorfer B, Horowitz JF, Klein S. Effect of gender on lipid kinetics during endurance exercise of moderate intensity in untrained subjects. Am J Physiol Endocrinol Metab 283: E58-E65, 2002.
26. Møller N, Jørgensen JO. Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocr Rev 30: 152-177, 2009.
27. Morio B, Holmback U, Gore D, Wolfe RR. Increased VLDL-TAG turnover during and after acute moderate-intensity exercise. Med Sci Sports Exerc 36: 801-806, 2004.
28. Nielsen S, Karpe F. Determinants of VLDL-triglycerides production. Curr Opin Lipidol 23: 321-326, 2012.
29. Nørrelund H, Nielsen S, Christiansen JS, Jørgensen JO, Møller N. Modulation of basal glucose metabolism and insulin sensitivity by growth hormone and free fatty acids during short-term fasting. Eur J Endocrinol 150: 779-787, 2004.
30. Roust LR, Jensen MD. Postprandial free fatty acid kinetics are abnormal in upper body obesity. Diabetes 42: 1567-1573, 1993.
31. Santomauro AT, Boden G, Silva ME, Rocha DM, Santos RF, Ursich MJ, Strassmann PG, Wajchenberg BL. Overnight lowering of free fatty acids with Acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects. Diabetes 48: 1836-1841, 1999.
32. Sidossis LS, Coggan AR, Gastaldelli A, Wolfe RR. A new correction factor for use in tracer estimations of plasma fatty acid oxidation. Am J Physiol Endocrinol Metab 269: E649-E656, 1995.
33. Sidossis LS, Wolfe RR, Coggan AR. Regulation of fatty acid oxidation in untrained vs. trained men during exercise. Am J Physiol Endocrinol Metab 274: E510-E515, 1998.
34. Sondergaard E, Rahbek I, Sorensen LP, Christiansen JS, Gormsen LC, Jensen MD, Nielsen S. Effects of exercise on VLDL-triglyceride oxidation and turnover. Am J Physiol Endocrinol Metab 300: E939-E944, 2011.
35. Sorensen LP, Andersen IR, Sondergaard E, Gormsen LC, Schmitz O, Christiansen JS, Nielsen S. Basal and insulin mediated VLDL-triglyceride kinetics in type 2 diabetic men. Diabetes 60: 88-96, 2011.
36. Sorensen LP, Gormsen LC, Nielsen S. VLDL-TG kinetics: a dual isotope study for quantifying VLDL-TG pool size, production rates, and fractional oxidation in humans. Am J Physiol Endocrinol Metab 297: E1324-E1330, 2009.
37. Sorensen LP, Sondergaard E, Nellemann B, Christiansen JS, Gormsen LC, Nielsen S. Increased VLDL-triglyceride secretion precedes impaired control of endogenous glucose production in obese, normoglycemic men. Diabetes 60: 2257-2264, 2011.
38. Tunaru S, Kero J, Schaub A, Wufka C, Blaukat A, Pfeffer K, Offermanns S. PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect. Nat Med 9: 352-355, 2003.
39. van Loon LJ, Koopman R, Schrauwen P, Stegen J, Wagenmakers AJ. The use of the [1,2-13C]acetate recovery factor in metabolic research. Eur J Appl Physiol 89: 377-383, 2003.
40. van Loon LJ, Koopman R, Stegen JH, Wagenmakers AJ, Keizer HA, Saris WH. Intramyocellular lipids form an important substrate source during moderate intensity exercise in endurance-trained males in a fasted state. J Physiol 553: 611-625, 2003.
41. van Loon LJ, Thomason-Hughes M, Constantin-Teodosiu D, Koopman R, Greenhaff PL, Hardie DG, Keizer HA, Saris WH, Wagenmakers AJ. Inhibition of adipose tissue lipolysis increases intramuscular lipid and glycogen use in vivo in humans. Am J Physiol Endocrinol Metab 289: E482-E493, 2005.
42. Vaag A, Skott P, Damsbo P, Gall MA, Richter EA, Beck-Nielsen H. Effect of the antilipolytic nicotinic acid analogue acipimox on whole-body and skeletal muscle glucose metabolism in patients with non-insulindependent diabetes mellitus. J Clin Invest 88: 1282-1290, 1991.
43. Watt MJ, Heigenhauser GJ, Spriet LL. Intramuscular triacylglycerol utilization in human skeletal muscle during exercise: is there a controversy? J Appl Physiol 93: 1185-1195, 2002.
44. Wojtaszewski JF, Mourtzakis M, Hillig T, Saltin B, Pilegaard H. Dissociation of AMPK activity and ACCbeta phosphorylation in human muscle during prolonged exercise. Biochem Biophys Res Commun 298: 309-316, 2002.
45. Wojtaszewski JF, Nielsen JN, Richter EA. Invited review: effect of acute exercise on insulin signaling and action in humans. J Appl Physiol 93: 384-392, 2002.
46. Wolfe RR, Klein S, Carraro F, Weber JM. Role of triglyceride-fatty acid cycle in controlling fat metabolism in humans during and after exercise. Am J Physiol Endocrinol Metab 258: E382-E389, 1990.
47. Wolfe RR, Peters EJ, Klein S, Holland OB, Rosenblatt J, Gary H Jr. Effect of short-term fasting on lipolytic responsiveness in normal and obese human subjects. Am J Physiol Endocrinol Metab 252: E189-E196, 1987.